secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001161697-23-000378
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical appoints Andrew LaFrence as CFO, effective July 10, 2023
---------------------------------------------------------------------

- Andrew LaFrence brings 39 years of finance/accounting experience; previously CFO at Vyant Bio and Surmodics, 26 years at KPMG.
- Base salary of $350k per year; eligible for annual cash bonus up to 50% of base salary.
- Inducement option to purchase 300,000 shares of common stock, vesting 25% annually over 4 years.
- Tom Adams, interim CFO, will continue as VP of Financial Planning and Analysis.
- LaFrence will support the Vision 2026 growth strategy and scaling of the business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169723000378/0001161697-23-000378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169723000378/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-23-000378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer